Russell Investments Group’s Viridian Therapeutics VRDN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.59M	Buy	234,551 +41,072	+21%	+$1.22M	﹤0.01%	1401
2025 Q4	$6.02M	Buy	193,479 +58,482	+43%	+$1.6M	0.01%	1201
2025 Q3	$2.91M	Buy	134,997 +47,112	+54%	+$850K	﹤0.01%	1647
2025 Q2	$1.23M	Sell	87,885 -110,373	-56%	-$1.5M	﹤0.01%	1962
2025 Q1	$2.67M	Sell	198,258 -181,338	-48%	-$3.09M	﹤0.01%	1534
2024 Q4	$7.28M	Sell	379,596 -62,738	-14%	-$1.36M	0.01%	973
2024 Q3	$10.1M	Buy	442,334 +92,703	+27%	+$1.52M	0.01%	835
2024 Q2	$4.55M	Buy	349,631 +28,025	+9%	+$388K	0.01%	1195
2024 Q1	$5.63M	Sell	321,606 -7,878	-2%	-$153K	0.01%	1113
2023 Q4	$7.18M	Buy	329,484 +30,343	+10%	+$479K	0.01%	960
2023 Q3	$4.59M	Buy	299,141 +195,616	+189%	+$3.73M	0.01%	1124
2023 Q2	$2.46M	Buy	103,525 +18,790	+22%	+$482K	﹤0.01%	1452
2023 Q1	$2.16M	Sell	84,735 -392	-0.5%	-$12.6K	﹤0.01%	1538
2022 Q4	$2.49M	Buy	85,127 +40,328	+90%	+$929K	0.01%	1455
2022 Q3	$917K	Buy	+44,799	New	+$805K	﹤0.01%	1976
2017 Q4	–	Sell	-1,072	Closed	-$147K	–	3013
2017 Q3	$147K	Buy	+1,072	New	+$180K	﹤0.01%	2720